FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases

FOLFIRINOX is a standard chemotherapeutic regimen for patients with advanced pancreatic cancer who have a good performance status. In this study, we present the case of a 64-year-old male who developed dysarthria following FOLFIRINOX treatment, and review all four cases of dysarthria encountered amo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: MATSUOKA, AYUMU, MAEDA, OSAMU, INADA-INOUE, MEGUMI, OHNO, EIZABURO, HIROOKA, YOSHIKI, YOKOYAMA, YUKIHIRO, FUJII, TSUTOMU, NAGINO, MASATO, GOTO, HIDEMI, ANDO, YUICHI
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2015
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4579986/
https://ncbi.nlm.nih.gov/pubmed/26622908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3591
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi